Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Agnelli

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Molecular Medicine (Cambridge, Mass.)|March 12, 2020
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approachMonica Colombo, Davide Bagnara, Daniele Reverberi, et al.
Plos Genetics|January 3, 2023
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, et al.
Non-Coding RNA|March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical OutcomeDomenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Biomedicines|July 29, 2023
A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma PeritoneiShigeki Kusamura, Adele Busico, Elena Conca, et al.
Journal for Immunotherapy of Cancer|June 15, 2021
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cellsGiovanni Fucà, Margherita Ambrosini, Luca Agnelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2010
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletionLaura Mosca, Sonia Fabris, Marta Lionetti, et al.
Plos One|July 7, 2011
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaFederico Colombo, Francesca Baldan, Silvia Mazzucchelli, et al.
BMC Medical Genomics|September 6, 2013
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemiaDomenica Ronchetti, Laura Mosca, Giovanna Cutrona, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Tumori|April 27, 2024
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trialsLuca Agnelli, Andrea Villa, Fouziah Butt, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Molecular Medicine (Cambridge, Mass.)|March 12, 2020
Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approachMonica Colombo, Davide Bagnara, Daniele Reverberi, et al.
Plos Genetics|January 3, 2023
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, et al.
Non-Coding RNA|March 19, 2020
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical OutcomeDomenica Ronchetti, Vanessa Favasuli, Paola Monti, et al.
Biomedicines|July 29, 2023
A2AR Expression and Immunosuppressive Environment Independent of <i>KRAS</i> and <i>GNAS</i> Mutations in Pseudomyxoma PeritoneiShigeki Kusamura, Adele Busico, Elena Conca, et al.
Journal for Immunotherapy of Cancer|June 15, 2021
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cellsGiovanni Fucà, Margherita Ambrosini, Luca Agnelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2010
Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletionLaura Mosca, Sonia Fabris, Marta Lionetti, et al.
Plos One|July 7, 2011
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaFederico Colombo, Francesca Baldan, Silvia Mazzucchelli, et al.
BMC Medical Genomics|September 6, 2013
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemiaDomenica Ronchetti, Laura Mosca, Giovanna Cutrona, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Tumori|April 27, 2024
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trialsLuca Agnelli, Andrea Villa, Fouziah Butt, et al.
Pageof 12